Glass House Brands Inc. (GLAS)
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
$5.35−2.55%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $504M
- Forward P/E
- 23.8
- 52-week range
- $4.97 – $13.93
- 52-week change
- −32.22%
- EPS (trailing)
- −$0.74
- Next earnings
- Nov 11, 2026
Fiscal year to Dec 2025
- Revenue
- $182M (−9.42%)
- Net income
- −$29.7M
- Operating margin
- −9.1%
- Diluted EPS
- −$0.55
- Free cash flow
- −$15.7M
From the company’s annual report on SEC EDGAR.
About Glass House Brands Inc.
Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. It operates through three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods. The Retail segment owns, and operates retail cannabis stores, and dispensary operation management services. The Wholesale Biomass segment includes propagation, nursery, flowering canopy, dries, processes, and distributes cannabis biomass. The Cannabis-Related Consumer Packaged Goods segment manufactures, extracts, infuse, conversion, packaging, and distributes cannabis products. The company cultivates, manufactures, and distributes cannabis bulk flowers and trims to wholesalers; and consumer packaged goods to third-party retail stores in California. It also offers raw cannabis, cannabis oil, and cannabis consumer goods; edibles; flower jars and bags; single, multi-pack, and infused pre-rolls; tinctures; biomass for distributors; and online payment processing, in-store pickup and home delivery services for adult-use and medicinal-use customers.
Headquarters: Long Beach, United States · 357 employees · glasshousebrands.com